To The Moon

The economic cycles have always been with us. But the frequency of boom and bust cycles has certainly increased in the last couple of decades.If the volatility of the stock market keeps you awake at night, this article is for you.The market has been rallying for some time now. Will the bull rally continue in 2024?This article addresses some of the questions and recommends how to invest fresh capital. Galeanu Mihai Markets are continuing their recovery and shooting for another rally. In fact, the S&P 500 gained 9% just in the last month and is up more than 20% in 2023. So, are the clouds of uncertainty and the possibility of a recession over?Well, the answer to the occurrence of a recession is not clear. The bigger question is how deep or shallow the recession will be if it arrives in 2024. Also, an even bigger question remains: What actions is the Fed going to take in 2024?How long are interest rates going to remain high?

RedHill said it has received new non-dilutive external funding for a Phase 2 study of its oral antiviral drug RHB-107 in the treatment of early COVID-19. The Israeli company said the approximately $4.8M in funding will cover the entirety of the RHB-107 arm of the ACESO PROTECT study for early COVID-19 outpatient treatment. The study, which will have 300 patients, is expected to begin enrollment in the coming weeks and be completed by the end of 2024. If approved, the product could provide an additional option to Pfizer’s Paxlovid in the early COVID-19 treatment space, RedHill said. More on RedHill RedHill stock nearly doubles in value pre-market on a five-year FDA exclusivity grant Financial information for RedHill

Nvidia may be changing the world, but its stock is too pricey.